Skip to main content

A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects with Chronic Hepatitis C Previously Treated with an NS5A Inhibitor + Sofosbuvir Therapy

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

University of Florida

Start Date

March 20, 2017

End Date

April 30, 2019
 

Administered By

Medicine, Gastroenterology

Awarded By

University of Florida

Start Date

March 20, 2017

End Date

April 30, 2019